Norges Bank’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $39.1M | Buy |
+1,184,072
| New | +$39.1M | ﹤0.01% | 1048 |
|
|
2025
Q1 | – | Sell |
-989,721
| Closed | -$46.6M | – | 447 |
|
|
2024
Q4 | $46.6M | Buy |
+989,721
| New | +$46.6M | 0.01% | 989 |
|
|
2024
Q3 | – | Sell |
-799,664
| Closed | -$43.3M | – | 453 |
|
|
2024
Q2 | $43.3M | Sell |
799,664
-183,097
| -19% | -$9.92M | 0.01% | 961 |
|
|
2024
Q1 | $68.9M | Buy |
982,761
+260,532
| +36% | +$18.3M | 0.01% | 794 |
|
|
2023
Q4 | $60.3M | Sell |
722,229
-107,278
| -13% | -$8.96M | 0.01% | 819 |
|
|
2023
Q3 | $24.4M | Buy |
829,507
+78,057
| +10% | +$2.3M | 0.01% | 1151 |
|
|
2023
Q2 | $24.5M | Buy |
751,450
+13,291
| +2% | +$434K | ﹤0.01% | 1169 |
|
|
2023
Q1 | $26M | Sell |
738,159
-101,197
| -12% | -$3.56M | 0.01% | 1149 |
|
|
2022
Q4 | $38.5M | Buy |
839,356
+15,860
| +2% | +$727K | 0.01% | 919 |
|
|
2022
Q3 | $39.9M | Buy |
823,496
+70,762
| +9% | +$3.43M | 0.01% | 867 |
|
|
2022
Q2 | $29.6M | Buy |
752,734
+156,355
| +26% | +$6.14M | 0.01% | 1039 |
|
|
2022
Q1 | $22M | Buy |
+596,379
| New | +$22M | ﹤0.01% | 1352 |
|
|
2020
Q4 | – | Sell |
-207,200
| Closed | -$4.49M | – | 2125 |
|
|
2020
Q3 | $4.49M | Hold |
207,200
| – | – | ﹤0.01% | 1880 |
|
|
2020
Q2 | $4.88M | Buy |
+207,200
| New | +$4.88M | ﹤0.01% | 1867 |
|
|
2017
Q1 | – | Sell |
-80,321
| Closed | -$976K | – | 2148 |
|
|
2016
Q4 | $976K | Buy |
+80,321
| New | +$976K | ﹤0.01% | 2055 |
|